{"id":523,"date":"2023-10-04T19:33:48","date_gmt":"2023-10-04T19:33:48","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=523"},"modified":"2023-10-11T19:35:24","modified_gmt":"2023-10-11T19:35:24","slug":"bevigilant-orafusion-system-released-in-italy","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/it\/sistema-bevigilant-orafusion-rilasciato-in-italia\/","title":{"rendered":"Sistema BeVigilant\u2122 OraFusion\u2122 rilasciato in Italia"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 bloccato=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201dripeti\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.22.2\u2033 header_2_font_size=\u201d24px\u201d header_2_line_height=\u201d1.4em\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201dripeti\u201d custom_padding =\u201d25px||||false|false\u201d global_colors_info=&quot;{}&quot;]<\/p>\n<h2>Vigilant Biosciences\u00ae guida la lotta contro il cancro orale<\/h2>\n<p>Lakeway, Texas (4 ottobre 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), uno sviluppatore leader del settore di soluzioni all&#039;avanguardia che accelerano il rilevamento del cancro orale, annuncia il rilascio del suo prodotto di punta, BeVigilant\u2122 Sistema OraFusion\u2122, in Italia. <\/p>\n<p>Il sistema BeVigilant\u2122 OraFusion\u2122 \u00e8 un dispositivo innovativo che effettua una valutazione del rischio di cancro orale presso il punto di cura. Il sistema fornisce un risultato accurato della valutazione del rischio attraverso l&#039;analisi combinata delle concentrazioni di biomarcatori in fase iniziale e la valutazione intelligente dei fattori di rischio clinici basata su software. Questa analisi integrata fornisce ai medici in prima linea i dati necessari per prendere decisioni informate sul trattamento dei pazienti con lesioni orali.<\/p>\n<p>&quot;Fin dall&#039;inizio, Vigilant ha mirato ad aumentare il tasso di sopravvivenza del cancro orale attraverso la diagnosi e l&#039;intervento precoce&quot;, ha affermato Bill Brodie, CEO di Vigilant Biosciences\u00ae. \u201cIl sistema BeVigilant\u2122 OraFusion\u2122 sta portando a compimento questo obiettivo, aiutando i medici nella valutazione del cancro orale a rilevarlo prima che mai. Facendo il passo successivo nel rimodellare la rilevazione del cancro orale, crediamo che la nostra tecnologia porter\u00e0 speranza e risultati salvavita a coloro che sono colpiti da questa malattia\u201d.<\/p>\n<p>Quando i pazienti vengono indirizzati a cure specialistiche durante le prime fasi del cancro orale, il trattamento \u00e8 spesso meno invasivo e pi\u00f9 efficace, portando a risultati significativamente migliori. L&#039;attuale tasso di sopravvivenza del cancro orale \u00e8 50%, ma la diagnosi precoce pu\u00f2 aumentare sostanzialmente il tasso di sopravvivenza fino a 90%. <\/p>\n<p>Vigilant Biosciences\u00ae continua a tracciare la strada nella lotta contro il cancro orale con soluzioni semplici, accurate ed economicamente vantaggiose che consentono la diagnosi precoce, un intervento efficace e risultati migliori. Per ulteriori informazioni su Vigilant Biosciences\u00ae e i suoi prodotti, visitare il sito <a href=\"https:\/\/vigilantbiosciences.com\/it\/\">https:\/\/vigilantbiosciences.com\/<\/a>. <\/p>\n<p>Nota: il sistema BeVigilant\u2122 OraFusion\u2122 non \u00e8 disponibile per la vendita negli Stati Uniti<\/p>\n<p><strong>Informazioni su Vigilant Biosciences\u00ae, Inc.<\/strong><br \/>\nVigilant Biosciences\u00ae \u00e8 un innovatore e sviluppatore leader di soluzioni che aiutano i medici nella diagnosi precoce del cancro orale. La linea di prodotti BeVigilant\u2122 di Vigilant comprende test point-of-care semplici, accurati ed economici, che consentono agli operatori sanitari di migliorare la vita attraverso un intervento precoce. Scopri di pi\u00f9 su Vigilant Biosciences\u00ae su <a href=\"https:\/\/vigilantbiosciences.com\/it\/\">https:\/\/vigilantbiosciences.com\/<\/a>.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Vigilant Biosciences\u00ae guida la lotta contro il cancro orale Lakeway, Texas (4 ottobre 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), uno sviluppatore leader del settore di soluzioni all&#039;avanguardia che accelerano il rilevamento del cancro orale, annuncia il lancio in Italia del suo prodotto di punta, il sistema BeVigilant\u2122 OraFusion\u2122. Il sistema BeVigilant\u2122 OraFusion\u2122 \u00e8 un dispositivo innovativo che amministra un [\u2026]<\/p>","protected":false},"author":3,"featured_media":527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/it\/sistema-bevigilant-orafusion-rilasciato-in-italia\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/it\/sistema-bevigilant-orafusion-rilasciato-in-italia\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-04T19:33:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T19:35:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\",\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"description\":\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/it\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/it\/sistema-bevigilant-orafusion-rilasciato-in-italia\/","og_locale":"it_IT","og_type":"article","og_title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","og_description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","og_url":"https:\/\/vigilantbiosciences.com\/it\/sistema-bevigilant-orafusion-rilasciato-in-italia\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-04T19:33:48+00:00","article_modified_time":"2023-10-11T19:35:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"dex.manley","Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy","datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"wordCount":431,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","url":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/it\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/posts\/523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/media\/527"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/it\/wp-json\/wp\/v2\/tags?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}